# IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

> **NCT04335890** · PHASE1 · COMPLETED · sponsor: **Hasumi International Research Foundation** · enrollment: 17 (actual)

## Conditions studied

- Melanoma, Uveal Metastatic

## Interventions

- **BIOLOGICAL:** Vaccination with IKKb matured Dendritic Cells

## Key facts

- **NCT ID:** NCT04335890
- **Lead sponsor:** Hasumi International Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-24
- **Primary completion:** 2022-09-20
- **Final completion:** 2024-11-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04335890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04335890, "IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04335890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*